Silencing a brain receptor curbs cancer cachexia and boosts mouse survival

A caller way has opened toward stopping cancer-associated cachexia, a devastating complication that gradually wastes patients away. A KAIST probe squad has developed an RNA-based therapeutic strategy that blocks a encephalon awesome to forestall musculus nonaccomplishment and widen survival.